Found 7 matching trials
A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer
PHASE2In patients with recurrent or metastatic renal cell carcinoma, a preliminar...
Location
Tianjin Medical Unversity Second Hospital
Survival Prolongation by Rationale Innovative Genomics
PHASE1Patients with advanced/metastatic non-small cell lung cancer (NSCLC) with n...
Location
UCSD Moores Cancer Center
Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma
PHASE1This is a phase Ib, open, mono-center, dose-escalation, tolerability and ph...
Location
Beijing Cancer Hospital
Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
PHASE2The primary objective of this study is to evaluate whether the combination ...
Location
University of Colorado Cancer Center
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
PHASE1A First-in-Human Pharmacokinetic, Safety, and Tolerability Study of PF-0726...
Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma
NANext-Generation Sequencing and whole transcriptome RNA sequencing were used...
Location
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma
PHASE1This trial is a Phase I/II study in which a combination of duvelisib and ni...
Location
UPMC Hillman Cancer Center